Gerostate Alpha (YC S18): A pharmaceutical company dedicated to treating aging and age-related disease

1

💵 $2.1M raised in initial seed round, at $15M valuation cap

2

🧬 Team at the forefront of aging research for decades, collectively authoring 200+ papers

3

💪 Our platform delivers drug candidates to slow aging at a success rate of 20%

4

🐭 Funds will be used to test our candidates in aging mice

5

🧳 Executive chairman was former CEO of major pharma company, Sangamo Therapeutics

We know how to stop the threat of chronic disease; and we care because aging is 100% fatal

Gerostate Alpha (YC S18)